501 related articles for article (PubMed ID: 29446800)
41. Pandemic Vibrio cholerae shuts down site-specific recombination to retain an interbacterial defence mechanism.
Santoriello FJ; Michel L; Unterweger D; Pukatzki S
Nat Commun; 2020 Dec; 11(1):6246. PubMed ID: 33288753
[TBL] [Abstract][Full Text] [Related]
42. Vibrio cholerae Outer Membrane Vesicles Inhibit Bacteriophage Infection.
Reyes-Robles T; Dillard RS; Cairns LS; Silva-Valenzuela CA; Housman M; Ali A; Wright ER; Camilli A
J Bacteriol; 2018 Aug; 200(15):. PubMed ID: 29661863
[TBL] [Abstract][Full Text] [Related]
43. Dual expression profile of type VI secretion system immunity genes protects pandemic Vibrio cholerae.
Miyata ST; Unterweger D; Rudko SP; Pukatzki S
PLoS Pathog; 2013; 9(12):e1003752. PubMed ID: 24348240
[TBL] [Abstract][Full Text] [Related]
44. Type VI secretion system mutations reduced competitive fitness of classical Vibrio cholerae biotype.
Kostiuk B; Santoriello FJ; Diaz-Satizabal L; Bisaro F; Lee KJ; Dhody AN; Provenzano D; Unterweger D; Pukatzki S
Nat Commun; 2021 Nov; 12(1):6457. PubMed ID: 34753930
[TBL] [Abstract][Full Text] [Related]
45. A genomic island in Vibrio cholerae with VPI-1 site-specific recombination characteristics contains CRISPR-Cas and type VI secretion modules.
Labbate M; Orata FD; Petty NK; Jayatilleke ND; King WL; Kirchberger PC; Allen C; Mann G; Mutreja A; Thomson NR; Boucher Y; Charles IG
Sci Rep; 2016 Nov; 6():36891. PubMed ID: 27845364
[TBL] [Abstract][Full Text] [Related]
46. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
[TBL] [Abstract][Full Text] [Related]
47. Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area.
Faruque SM; Chowdhury N; Kamruzzaman M; Dziejman M; Rahman MH; Sack DA; Nair GB; Mekalanos JJ
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2123-8. PubMed ID: 14766976
[TBL] [Abstract][Full Text] [Related]
48. Niche adaptation limits bacteriophage predation of
Silva-Valenzuela CA; Camilli A
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1627-1632. PubMed ID: 30635420
[No Abstract] [Full Text] [Related]
49. Tracking Vibrio cholerae Cell-Cell Interactions during Infection Reveals Bacterial Population Dynamics within Intestinal Microenvironments.
Fu Y; Ho BT; Mekalanos JJ
Cell Host Microbe; 2018 Feb; 23(2):274-281.e2. PubMed ID: 29398650
[TBL] [Abstract][Full Text] [Related]
50. Widespread epidemic cholera caused by a restricted subset of Vibrio cholerae clones.
Moore S; Thomson N; Mutreja A; Piarroux R
Clin Microbiol Infect; 2014 May; 20(5):373-9. PubMed ID: 24575898
[TBL] [Abstract][Full Text] [Related]
51. Sequential displacement of Type VI Secretion System effector genes leads to evolution of diverse immunity gene arrays in Vibrio cholerae.
Kirchberger PC; Unterweger D; Provenzano D; Pukatzki S; Boucher Y
Sci Rep; 2017 Mar; 7():45133. PubMed ID: 28327641
[TBL] [Abstract][Full Text] [Related]
52. Response of Vibrio cholerae to Low-Temperature Shifts: CspV Regulation of Type VI Secretion, Biofilm Formation, and Association with Zooplankton.
Townsley L; Sison Mangus MP; Mehic S; Yildiz FH
Appl Environ Microbiol; 2016 Jul; 82(14):4441-52. PubMed ID: 27208110
[TBL] [Abstract][Full Text] [Related]
53. Interbacterial competition and anti-predatory behaviour of environmental Vibrio cholerae strains.
Drebes Dörr NC; Blokesch M
Environ Microbiol; 2020 Oct; 22(10):4485-4504. PubMed ID: 32885535
[TBL] [Abstract][Full Text] [Related]
54. c-di-GMP inhibits LonA-dependent proteolysis of TfoY in Vibrio cholerae.
Joshi A; Mahmoud SA; Kim SK; Ogdahl JL; Lee VT; Chien P; Yildiz FH
PLoS Genet; 2020 Jun; 16(6):e1008897. PubMed ID: 32589664
[TBL] [Abstract][Full Text] [Related]
55. When the pandemic opts for the lockdown: Secretion system evolution in the cholera bacterium.
Santoriello FJ; Pukatzki S
Microb Cell; 2021 Feb; 8(3):69-72. PubMed ID: 33681340
[No Abstract] [Full Text] [Related]
56. Genes Activated by
List C; Grutsch A; Radler C; Cakar F; Zingl FG; Schild-Prüfert K; Schild S
mSphere; 2018; 3(3):. PubMed ID: 29794057
[TBL] [Abstract][Full Text] [Related]
57. Vibrio cholerae infection, novel drug targets and phage therapy.
Fazil MH; Singh DV
Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
[TBL] [Abstract][Full Text] [Related]
58. A Tail Fiber Protein and a Receptor-Binding Protein Mediate ICP2 Bacteriophage Interactions with Vibrio cholerae OmpU.
Lim ANW; Yen M; Seed KD; Lazinski DW; Camilli A
J Bacteriol; 2021 Jun; 203(13):e0014121. PubMed ID: 33875544
[TBL] [Abstract][Full Text] [Related]
59. Comparative phenotypic characterization of Vibrio cholerae isolates collected from aquatic environments of Georgia.
Kokashvili T; Elbakidze T; Jaiani E; Janelidze N; Kamkamidze G; Whitehouse C; Huq A; Tediashvili M
Georgian Med News; 2013 Nov; (224):55-62. PubMed ID: 24323966
[TBL] [Abstract][Full Text] [Related]
60. Genetic characterization of ØVC8 lytic phage for Vibrio cholerae O1.
Solís-Sánchez A; Hernández-Chiñas U; Navarro-Ocaña A; De la Mora J; Xicohtencatl-Cortes J; Eslava-Campos C
Virol J; 2016 Mar; 13():47. PubMed ID: 27000701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
